Francesco Semeraro
Francesco Semeraro
Professore Associato Oftalmologia, UniversitÓ degli Studi di Brescia
Verified email at
TitleCited byYear
Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma
L Quaranta, S Bettelli, MG Uva, F Semeraro, R Turano, E Gandolfo
Ophthalmology 110 (2), 359-362, 2003
Diabetic retinopathy: vascular and inflammatory disease.
F Semeraro, A Cancarini, R dell'Omo, S Rezzola, MR Romano, ...
J Diabetes Res. 2015 (2015;2015:582060. doi: 10.1155/2015/5820), 1-16, 2015
Novel aspects of Sj÷gren’s syndrome in 2012
A Tincani, L Andreoli, I Cavazzana, A Doria, M Favero, MG Fenini, ...
BMC medicine 11 (1), 93, 2013
Mechanism of inflammation in age-related macular degeneration
F Parmeggiani, MR Romano, C Costagliola, F Semeraro, C Incorvaia, ...
Mediators of inflammation 2012, 2012
Color Doppler imaging of ophthalmic artery blood flow velocity: a study of repeatability and agreement
L Quaranta, A Harris, F Donato, M Cassamali, F Semeraro, G Nascimbeni, ...
Ophthalmology 104 (4), 653-658, 1997
Comparison of smartphone ophthalmoscopy with slit-lamp biomicroscopy for grading diabetic retinopathy
A Russo, F Morescalchi, C Costagliola, L Delcassi, F Semeraro
American journal of ophthalmology 159 (2), 360-364. e1, 2015
Aflibercept in wet AMD: specific role and optimal use
F Semeraro, F Morescalchi, S Duse, F Parmeggiani, E Gambicorti, ...
Drug design, development and therapy 7, 711, 2013
Relationship between media-to-lumen ratio of subcutaneous small arteries and wall-to-lumen ratio of retinal arterioles evaluated noninvasively by scanning laser Doppler flowmetry
D Rizzoni, E Porteri, S Duse, C De Ciuceis, CA Rosei, E La Boria, ...
Journal of hypertension 30 (6), 1169-1175, 2012
Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications
C Campa, C Costagliola, C Incorvaia, C Sheridan, F Semeraro, ...
Mediators of inflammation 2010, 2010
Selective serotonin reuptake inhibitors: a review of its effects on intraocular pressure
C Costagliola, F Parmeggiani, F Semeraro, A Sebastiani
Current neuropharmacology 6 (4), 293-310, 2008
Proliferative vitreoretinopathy after eye injuries: an overexpression of growth factors and cytokines leading to a retinal keloid
F Morescalchi, S Duse, E Gambicorti, MR Romano, C Costagliola, ...
Mediators of inflammation 2013, 2013
Intravitreal bevacizumab (Avastin«) injection for neovascular glaucoma: a survey on 23 cases throughout 12‐month follow‐up
C Costagliola, U Cipollone, M Rinaldi, M Della Corte, F Semeraro, ...
British journal of clinical pharmacology 66 (5), 667-673, 2008
Therapeutic challenges to retinitis pigmentosa: from neuroprotection to gene therapy
J N Sahni, M Angi, C Irigoyen, F Semeraro, M R Romano, F Parmeggiani
Current genomics 12 (4), 276-284, 2011
Mechanism of inflammation in age-related macular degeneration: an up-to-date on genetic landmarks
F Parmeggiani, FS Sorrentino, MR Romano, C Costagliola, F Semeraro, ...
Mediators of inflammation 2013, 2013
Proteomic analyses of the vitreous humour
M Angi, H Kalirai, SE Coupland, BE Damato, F Semeraro, MR Romano
Mediators of inflammation 2012, 2012
Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration
E M Becerra, F Morescalchi, F Gandolfo, P Danzi, G Nascimbeni, ...
Current drug targets 12 (2), 149-172, 2011
Reduction in retinal nerve fiber layer thickness in migraine patients
S Gipponi, N Scaroni, E Venturelli, E Forbice, R Rao, P Liberini, ...
Neurological Sciences 34 (6), 841-845, 2013
Predicting the risk of diabetic retinopathy in type 2 diabetic patients
F Semeraro, G Parrinello, A Cancarini, L Pasquini, E Zarra, A Cimino, ...
Journal of Diabetes and its Complications 25 (5), 292-297, 2011
Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration
C Costagliola, L Agnifili, B Arcidiacono, S Duse, V Fasanella, ...
Expert opinion on biological therapy 12 (10), 1299-1313, 2012
Analysis of fibronectin, plasminogen activators and plasminogen in tear fluid as markers of corneal damage and repair
S Barlati, E Marchina, CA Quaranta, F Vigasio, F Semeraro
Experimental eye research 51 (1), 1-9, 1990
The system can't perform the operation now. Try again later.
Articles 1–20